Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
Protocol ID
PersoMed-I
Disease (Sub Disease)
Medulloblastoma
Diagnosis Stage
Newly diagnosed
Location
NSW
Sponsor
European Organisation for Research and Treatment of Cancer
Links
Trial Status
Open
Sites
Sydney Children's Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
15 Years and older (Child, Adult, Older Adult )
International registry ID's
NCT04402073
| Study Title | Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma |
|---|---|
| Protocol ID | PersoMed-I |
| Disease (Sub Disease) | Medulloblastoma |
| Diagnosis Stage | Newly diagnosed |
| Location | NSW |
| Sponsor | European Organisation for Research and Treatment of Cancer |
| Links | https://clinicaltrials.gov/study/NCT04402073 |
| Trial Status | Open |
| Trial Open Date | 11/11/2022 |
| Sites | Sydney Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 2 |
| Age Eligibility | 15 Years and older (Child, Adult, Older Adult ) |
| International registry ID's | NCT04402073 |